#United States #Albuquerque #MediNatura #ReBoost Nasal Spray #ClearLife Nasal Spray

Nationwide Recall of MediNatura's Nasal Sprays

MediNatura New Mexico, Inc. has announced a voluntary recall of all lots of its ReBoost Nasal Spray and ClearLife Allergy Nasal Spray due to found microbial contamination, which poses serious health risks. The announcement made on December 16, 2025, has raised significant concerns for consumers, especially those with weakened immune systems.

Contamination Details

The company discovered that both nasal sprays contain yeast, mold, and a specific microbe known as Achromobacter, detected at levels exceeding safety specifications. This news follows ongoing investigative efforts by MediNatura to assess the safety and compliance of its products. The contamination can potentially lead to severe health effects for vulnerable groups, thus prompting immediate action to ensure public safety.

Product Information

The ReBoost Nasal Spray is designed to provide temporary relief from nasal congestion, sinus pressure, and other related symptoms. It is packaged in a 20mL bottle that comes in a white and yellow carton. Its NDC number is 62795-4005-9, and the UPC is 787647 10186 3. The recall involves all lots that remain within their expiration date, which runs from December 2022 to December 2025.

On the other hand, the ClearLife Allergy Nasal Spray, which aids in alleviating mild allergy symptoms, comes in the same 20mL bottle format but is packaged in a white and green carton. Its NDC number is 62795-4006-9, with a UPC of 787647 10188 7. The recall also encompasses all lots that have expiration dates between December 2022 and December 2025.

Consumer Advisory

To ensure safety, all consumers who have purchased either of these nasal sprays are advised to immediately halt their use. For those who bought directly from MediNatura, they should contact the company to arrange for refunds. Retail customers can return the product to its original place of purchase for a full refund.

MediNatura encourages anyone affected by the nasal sprays to reach out to healthcare providers if they have experienced any adverse effects related to these products. Questions regarding the recall can be directed to MediNatura via phone at 800-621-7644 or by sending an email to [email protected].

Next Steps

To effectively handle any adverse reactions or incidents related to these nasal sprays, consumers can report their experiences to the FDA's MedWatch Adverse Event Reporting program. This can be done online or through physical forms available on the FDA's website.

This recall showcases MediNatura's commitment to customer safety and health, emphasizing the importance of consumer awareness regarding product quality and integrity. The company assures that further steps will be taken to mitigate risks and enhance product safety in the future.

In light of these developments, stay informed about active recalls to ensure the safety of your well-being and that of those around you.

• ---

For more updates on product recalls, follow MediNatura’s official communications channels and ensure a proactive approach to health and safety.